Corporations

Swiss Freeze Biotech Rollout

Swiss citizens backed a five-year moratorium on commercial release of genetically modified plants and animals, despite opposition from their government and industry groups. Fifty-five percent of the voters backed the moratorium. The ballot initiative followed the collection of 100,000 signatures opposing a 2004 law approving commercial release of genetically engineered crops. "All the farmers' organisations were behind this proposal, which they see as a chance for Swiss agriculture," Daniel Ammann, a spokesman for the pro-moratorium coalition, told Reuters.

No

Not So Tough On Drugs After All

Professor Andrew Herx-heimer, emeritus fellow at the UK Cochrane Centre, told the British Medical Journal that changes to the British drug industry's voluntary code of practice were minimal. "This is very competent window dressing but not much has changed at all," he said.

No

Whatever the Skin Color, Inside Are Black Lungs

The Campaign for Tobacco-Free Kids, the National Latino Council on Alcohol and Tobacco Prevention, and Floridians for Youth Tobacco Education warn that the tobacco industry is increasingly targeting Latino children.

No

Disease Is Also Sell

As "part of a cultural shift that increasingly sees health problems as lifestyles rather than diseases," food marketers are targeting the chronically ill "as the new much-reach demographic." Groceries have "heart healthy" sections because there are more than 70 million U.S. residents with heart problems, representing "$71 billion in annual buying power." The nation's 21 million diabetics "command about $14 billion" and "about two-thirds of American adults are overweight or obese," writes the Associated Press.

No

Oil Industry Concerned Its Image Is Tanking

The PR firm Edelman "is working with the American Petroleum Institute (API), the oil industry's primary lobbying group, on a public issues campaign aimed at convincing Americans that the industry is facing severe challenges, even as its members pull in record quarterly profits," reports PR Week.

No

Lawyers, Drugs and Ad Money

West Virginia's Pharmaceutical Cost Management Council unanimously approved "a financial disclosure form that would require pharmaceutical companies to reveal how much they spend on advertising and promotion of brand-name drugs" in the state, as well as any "gifts, grants or payments to physicians" in excess of $25.

No

Pages

Subscribe to Corporations